JERUSALEM, March 15, 2021 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") announced today that it has entered into a definitive agreement for a business combination with ...

A phase 3 trial of Intec Pharma’s Parkinson's disease drug has missed its primary endpoint, sparking a steep decline in the company’s stock. The candidate uses a drug delivery system designed to ...

"We entered 2020 with a focused agenda for leveraging our Accordion Pill platform in both the near- and long-term, with goals to outlicence our late-stage Parkinson's disease program, to advance our ...

Intec Pharma’s Parkinson’s gradual release disease drug trial has missed its primary endpoint, causing the biotech’s share price to crash. Shares in the US biotech fell from an opening price of $3.43 ...

U.S. billing firm CSG Systems will buy Intec Telecom Systems, a British-based rival, for 236.7 million pounds ($370.9 million), in a deal supported by private equity firm General Atlantic, which has ...

SANTA MONICA, Calif., Aug. 19, 2025 /PRNewswire/ -- Intec Bioplastics, Inc. is proud to announce their new customer incentive Buy Back Program, which is focused on used stretch wrap film and stretch ...

After whisperings in the industry about possible take-overs by various unnamed suitors, the buy-out of billing system vendor Intec finally looks set to be more than just a rumour this time around. US ...